Ly
me borreliosis is the
most co
mmon tick-borne disease in the northern he
misphere. It is a
multisyste
m disease caused by
m>Borrelia burgdorferim> sensu lato genospecies and characterised by tissue localisation and low spirochaetae
mia. In this study we ai
med to describe a novel
m>Borreliam> species causing Ly
me borreliosis in the USA.
Methods
At the Mayo clinic, from 2003 to 2014, we tested routine clinical diagnostic specimens from patients in the USA with PCR targeting the m>oppA1m> gene of m>B burgdorferim> sensu lato. We identified positive specimens with an atypical PCR result (melting temperature outside of the expected range) by sequencing, microscopy, or culture. We collected m>Ixodes scapularism> ticks from regions of suspected patient tick exposure and tested them by m>oppA1m> PCR.
Findings
100 545 specimens were submitted by physicians for routine PCR from Jan 1, 2003 to Sept 30, 2014. From these samples, six clinical specimens (five blood, one synovial fluid) yielded an atypical m>oppA1m> PCR product, but no atypical results were detected before 2012. Five of the six patients with atypical PCR results had presented with fever, four had diffuse or focal rash, three had symptoms suggestive of neurological inclusion, and two were admitted to hospital. The sixth patient presented with knee pain and swelling. Motile spirochaetes were seen in blood samples from one patient and cultured from blood samples from two patients. Among the five blood specimens, the median m>oppA1m> copy number was 180 times higher than that in 13 specimens that tested positive for m>B burgdorferim> sensu stricto during the same time period. Multigene sequencing identified the spirochaete as a novel m>B burgdorferim> sensu lato genospecies. This same genospecies was detected in ticks collected at a probable patient exposure site.
Interpretation
We describe a new pathogenic m>Borrelia burgdorferim> sensu lato genospecies (candidatus m>Borrelia mayoniim>) in the upper midwestern USA, which causes Lyme borreliosis with unusually high spirochaetaemia. Clinicians should be aware of this new m>B burgdorferim> sensu lato genospecies, its distinct clinical features, and the usefulness of m>oppA1m> PCR for diagnosis.
Funding
US Centers for Disease Control and Prevention Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) Cooperative Agreement and Mayo Clinic Small Grant programme.